Lv3
330 积分 2026-03-27 加入
HER2-targeted therapies beyond breast cancer — an update
5天前
已完结
A novel CRLF2-targeted antibody-drug conjugate exhibits potent anti-leukemic activity against Ph-like acute lymphoblastic leukemia
7天前
已完结
Heterogeneity and plasticity of cancer-associated fibroblasts
16天前
已完结
Harnessing biosynthetic logic for next-generation ADC payloads
1个月前
已完结
Conditionally Activatable Antibody Platforms: Mechanisms, Modalities, and Clinical Translation Potential
1个月前
已完结
A MERTK-Targeting Antibody-Drug Conjugate Selectively Depletes M2 Tumor-Associated Macrophages and MERTK-Expressing Cancer Cells
1个月前
已完结
Geographic Shifts in Early-Stage Biopharmaceutical Innovation
2个月前
已关闭
The Geography of Pharmaceutical Innovation The US and China in a New World Order
2个月前
已完结
Payload Diversification Overcomes Resistance and Guides Sequential Antibody–Drug Conjugate Therapy in Breast Cancer
2个月前
已完结
ADME investigations of novel therapeutic modalities: challenges and opportunities 2025
2个月前
已完结
皖公网安备34019202002308
